← Back
$KROS All transactions

Keros Therapeutics, Inc.

A

$ Value

$0

Shares

5,250

Price

$0

Filed

Jun 6

Insider

Name

BIENAIME JEAN JACQUES

Title

CIK

0001221590

Roles

Director

Transaction Details

Transaction Date

2025-06-04

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,450

Footnotes

Represents a restricted stock unit ("RSU") award. The RSUs fully vest on the earlier of (A) June 4, 2026 and (B) the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. | The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.

Filing Info

Accession No.

0001415889-25-015971

Form Type

4

Issuer CIK

0001664710

BIENAIME JEAN JACQUES's History

Date Ticker Type Value
2026-04-15 KROS $12K
2025-06-10 IMNM A $0
2025-06-10 INCY A $0
2025-06-10 INCY A $0
2025-06-04 KROS A $0
2025-06-04 KROS A $0
2025-06-03 IMNM $47K

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $12K 2026-04-15
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
2026-04-02
Cho Esther
Chief Legal Officer
2026-02-24